Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/All kind of people
man pills

These guys are crowdfunding the answer to the male contraceptive pill

Does this mean we’ve reached peak crowdfunding?

MALE ORAL CONTRACEPTION is a concept still in its infancy – particularly when compared to the female variety, which has been on the go for the last 55 years in the US.

The male pill has been mooted for some time, but the popularity of condoms would prove a difficult monopoly to break given the other protections they afford.

Still, a team of Americans are trying to reverse the trend. And they’re funding their approach via crowdfunding.

The group, known as the Male Contraception Initiative (MCI), has launched a crowdfunding effort on Indiegogo.

Male Contraception Initiative / YouTube

They’re recommending a proposal by Dr Gary Flynn of Stanford University, California.

His approach is targeting a protein unique to the male testes which is “critical to the proper production of sperm” according to a release by the group.

The “non-hormonal nature” of the drug Flynn et al are developing suggests a “low risk of side effects” apparently.

Mind you, they would say that wouldn’t they.

It also seems that the funding appeal has a ways to go – just 10% of the MCI’s target has been collected thus far, with 21 days of the appeal remaining.

Male Contraception Initiative / YouTube

Read: How many times a week? Sex in Ireland by the numbers

Read: Ireland’s Sex Shops: ‘Everyone has a kink, they just might not know it yet’

Your Voice
Readers Comments
26
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.